Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion.
Changcheng TaoKai ZhangZonggui TaoYue LiuAnke WuLiming WangQinfu FengFan WuWeiqi RongJianxiong WuPublished in: Cancer reports (Hoboken, N.J.) (2023)
IORT+LR provided safe, feasible treatment for patients with centrally located HCC with MVI, along with an improvement in prognosis and lower early recurrence rates.